Stigmasterol inhibited the growth of skin carcinoma through elevated levels of antioxidative enzymes (glutathione, catalase, and superoxide dismutase) and reduced lipid oxidation and DNA damage [39]. The gene discussed is CAT; the disease is skin carcinoma.